| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Editorial Board
|
|
|
|
22 |
9 |
p. A1-A2
|
artikel
|
| 2 |
Efficacy and Safety of Generic Dasatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: A Multicenter Prospective Study in China
|
Yu, Wenjuan
|
|
|
22 |
9 |
p. e867-e873
|
artikel
|
| 3 |
Epigenetic Aberrations and Targets in Peripheral T-Cell Lymphoma
|
Atallah-Yunes, Suheil Albert
|
|
|
22 |
9 |
p. 659-665
|
artikel
|
| 4 |
Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes
|
Zeidan, Amer M.
|
|
|
22 |
9 |
p. 670-679
|
artikel
|
| 5 |
Impact of Lenalidomide Treatment on Overall Survival in Patients With Lower-Risk, Transfusion-Dependent Myelodysplastic Syndromes
|
Santini, Valeria
|
|
|
22 |
9 |
p. e874-e883
|
artikel
|
| 6 |
Long-Term Complete Clinical and Hematological Response With Bortezomib: The Report of a Case With TEM(P)I Syndrome and a Review of the Literature
|
Undar, Levent
|
|
|
22 |
9 |
p. 702-707
|
artikel
|
| 7 |
Matching-Adjusted Indirect Treatment Comparison to Assess the Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 Versus Belantamab Mafodotin in DREAMM-2, Selinexor-Dexamethasone in STORM Part 2, and Melphalan Flufenamide-Dexamethasone in HORIZON for the Treatment of Patients With Triple-Class Exposed Relapsed or Refractory Multiple Myeloma
|
Weisel, Katja
|
|
|
22 |
9 |
p. 690-701
|
artikel
|
| 8 |
Multiple Myeloma: Impact of Time to Transplant on the Outcome
|
Kumar, Lalit
|
|
|
22 |
9 |
p. e826-e835
|
artikel
|
| 9 |
Patient Preferences for Benefits, Risks, and Administration Route of Hypomethylating Agents in Myelodysplastic Syndromes
|
Zeidan, Amer M.
|
|
|
22 |
9 |
p. e853-e866
|
artikel
|
| 10 |
Peripheral Blood Involvement at Staging in Patients With Aggressive Peripheral T-Cell Lymphoma
|
Avery, Jonathan
|
|
|
22 |
9 |
p. 680-689
|
artikel
|
| 11 |
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma
|
Tamariz-Amador, Luis-Esteban
|
|
|
22 |
9 |
p. e844-e852
|
artikel
|
| 12 |
SOHO State of the Art Updates and Next Questions | Beyond BCL-2 Inhibition in Acute Myeloid Leukemia: Other Approaches to Leverage the Apoptotic Pathway
|
Maiti, Abhishek
|
|
|
22 |
9 |
p. 652-658
|
artikel
|
| 13 |
SOHO State of the Art Updates and Next Questions | Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangements: Diagnostic Pearls and Pitfalls
|
Kim, Annette S.
|
|
|
22 |
9 |
p. 643-651
|
artikel
|
| 14 |
Table of Contents
|
|
|
|
22 |
9 |
p. A3-A4
|
artikel
|
| 15 |
The Path Forward in Multiple Myeloma: 2021 Jan Waldenstrom Award Lecture
|
Rajkumar, S. Vincent
|
|
|
22 |
9 |
p. 666-669
|
artikel
|
| 16 |
Time to First Subsequent Salvage Therapy in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia Treated With Inotuzumab Ozogamicin in the Phase III INO-VATE Trial
|
Stelljes, Matthias
|
|
|
22 |
9 |
p. e836-e843
|
artikel
|
Tijdschrift beschrijving